1. Home
  2. KE vs CSTL Comparison

KE vs CSTL Comparison

Compare KE & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$24.63

Market Cap

634.9M

Sector

Technology

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$31.20

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
CSTL
Founded
1961
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
634.9M
722.8M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
KE
CSTL
Price
$24.63
$31.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$28.00
$45.50
AVG Volume (30 Days)
165.0K
462.8K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$1,486,727,000.00
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
$4.57
$12.69
P/E Ratio
$32.29
N/A
Revenue Growth
N/A
3.66
52 Week Low
$21.60
$17.72
52 Week High
$33.19
$44.28

Technical Indicators

Market Signals
Indicator
KE
CSTL
Relative Strength Index (RSI) 45.20 70.48
Support Level $23.56 $22.88
Resistance Level $26.95 $34.97
Average True Range (ATR) 1.23 1.79
MACD -0.04 0.32
Stochastic Oscillator 48.73 81.67

Price Performance

Historical Comparison
KE
CSTL

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: